Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

71 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Ovarian cancer stem cells: working towards the root of stemness.
Foster R, Buckanovich RJ, Rueda BR. Foster R, et al. Cancer Lett. 2013 Sep 10;338(1):147-57. doi: 10.1016/j.canlet.2012.10.023. Epub 2012 Nov 5. Cancer Lett. 2013. PMID: 23138176 Review.
Letal, A tumor-associated NKG2D immunoreceptor ligand, induces activation and expansion of effector immune cells.
Conejo-Garcia JR, Benencia F, Courreges MC, Khang E, Zhang L, Mohamed-Hadley A, Vinocur JM, Buckanovich RJ, Thompson CB, Levine B, Coukos G. Conejo-Garcia JR, et al. Cancer Biol Ther. 2003 Jul-Aug;2(4):446-51. doi: 10.4161/cbt.2.4.479. Cancer Biol Ther. 2003. PMID: 14508119
Transcriptional coactivator Drosophila eyes absent homologue 2 is up-regulated in epithelial ovarian cancer and promotes tumor growth.
Zhang L, Yang N, Huang J, Buckanovich RJ, Liang S, Barchetti A, Vezzani C, O'Brien-Jenkins A, Wang J, Ward MR, Courreges MC, Fracchioli S, Medina A, Katsaros D, Weber BL, Coukos G. Zhang L, et al. Cancer Res. 2005 Feb 1;65(3):925-32. Cancer Res. 2005. PMID: 15705892
Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity.
Huarte E, Cubillos-Ruiz JR, Nesbeth YC, Scarlett UK, Martinez DG, Buckanovich RJ, Benencia F, Stan RV, Keler T, Sarobe P, Sentman CL, Conejo-Garcia JR. Huarte E, et al. Cancer Res. 2008 Sep 15;68(18):7684-91. doi: 10.1158/0008-5472.CAN-08-1167. Epub 2008 Sep 3. Cancer Res. 2008. PMID: 18768667 Free PMC article.
Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer.
Pulaski HL, Spahlinger G, Silva IA, McLean K, Kueck AS, Reynolds RK, Coukos G, Conejo-Garcia JR, Buckanovich RJ. Pulaski HL, et al. J Transl Med. 2009 Jun 19;7:49. doi: 10.1186/1479-5876-7-49. J Transl Med. 2009. PMID: 19545375 Free PMC article.
F3-targeted cisplatin-hydrogel nanoparticles as an effective therapeutic that targets both murine and human ovarian tumor endothelial cells in vivo.
Winer I, Wang S, Lee YE, Fan W, Gong Y, Burgos-Ojeda D, Spahlinger G, Kopelman R, Buckanovich RJ. Winer I, et al. Cancer Res. 2010 Nov 1;70(21):8674-83. doi: 10.1158/0008-5472.CAN-10-1917. Epub 2010 Oct 19. Cancer Res. 2010. PMID: 20959470 Free PMC article.
The impact of diabetes on survival in women with ovarian cancer.
Bakhru A, Buckanovich RJ, Griggs JJ. Bakhru A, et al. Gynecol Oncol. 2011 Apr;121(1):106-11. doi: 10.1016/j.ygyno.2010.12.329. Epub 2011 Jan 13. Gynecol Oncol. 2011. PMID: 21236474
71 results
Jump to page